PKCα-KR CLL-like cells were responsive to IB treatment, as indicated by decreased Cyclin A expression, while proliferating human CLL cells did not illicit protein expression/synthesis responses to IB. Here, PRKCA is linked to B-cell chronic lymphocytic leukemia.